Santa Cruz claims cardiovascular research antibody market
We have released a new dataset today which highlights leading antibody suppliers and the top cited antibodies by research area.
One of the research areas we have looked at is cardiovascular research, where we have analysed 6,500 citations for 4,300 antibodies, supplied by 57 different companies.
Claiming the lion’s share of the market we see Santa Cruz Biotechnology, while AbD Serotec’s ‘Monoclonal Rat Anti Mouse F4/80 Clone Cl: A3-1’ tops the antibody list with 158 citations.
CiteAb lists over 65,000 Santa Cruz antibodies in total, and the company has strengths across a range of research areas. However, we recently reported that Santa Cruz has been losing market share overall in recent years, some of which has been captured by Abcam.
Here at CiteAb we produce antibody market datasets based on the analysis of hundreds of thousands of antibody citations. This data provides a quantitative, unique and independent view of the antibody market, allowing researchers to make more informed product development and marketing decisions.
To see a free sample showing the top three companies and top five antibodies for cardiovascular research please complete this form. If you’re interested in the full dataset then contact Matt by email.
~The CiteAb team
The full list of research areas available can be found in our headline blog post here.
